More than half of all patients diagnosed with bladder cancer have low-grade, noninvasive papillary tumors. Current treatment comprises initial transurethral resection (TUR), sometimes with immediate ...

Bladder cancer is cancer that forms in your urinary bladder, the muscular sac that stores urine. This balloon-shaped organ is located in your pelvis. Urine made by the kidneys goes into your bladder ...

For patients with interstitial cystitis (IC), transurethral fulguration (TUF) is effective for alleviating pelvic pain, according to a study published online April 3 in Neurourology and Urodynamics.

Active surveillance is a safe and cost-effective method to manage patients with recurrent papillary, low-grade, Ta bladder tumours. New long-term data from a large patient cohort confirm previous ...

UGN-102 shows a 79.6% complete response rate in recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer. UGN-102 offers a non-surgical alternative, avoiding cystoscopy and anesthesia, ...

Bladder hydrodistention significantly decreased nocturia in patients without NP who had non-Hunner type IC. In Hunner-type IC, bladder hydrodistention with fulguration of Hunner lesions significantly ...

The main goals of cystitis glandularis treatment are to relieve the symptoms and signs of the condition, such as irritative voiding symptoms, obstruction and bleeding. By treating the lesions one also ...

Pain control was achieved by TUF in 70.0 percent of 240 patients; 18 patients underwent cystectomy for intractable pain. (HealthDay News) — For patients with interstitial cystitis (IC), transurethral ...